Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial
2018 ◽
Vol 71
(1)
◽
pp. 33-41
◽
2003 ◽
Vol 25
(11)
◽
pp. 2738-2753
◽
2008 ◽
Vol 30
(1)
◽
pp. 84-97
◽
2008 ◽
Vol 30
(6)
◽
pp. 1089-1101
◽
2017 ◽
Vol 38
(29)
◽
pp. 2264-2276
◽
2019 ◽